We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Novel Device Measures Glucose in Urine

By LabMedica International staff writers
Posted on 01 Dec 2015
A device has been developed that can measure glucose in blood through the urine in the toilet, and it activates via smart phone bluetooth, recording the values on a daily basis.

One of the values taken into account for the design was the pain caused by the use of needles for monitoring glucose in blood, which is partly responsible of why patients with diabetes do not keep proper control of their disease.

Two young technologists at the Chihuahua Institute of Technology (Mexico) developed the device which has achieved international recognition, included being one of the 10 most outstanding creations among innovators under 35 delivered by the MIT Tech Review; it also won the Global Innovation Competition for Science and Technology for the Benefit of Mankind (GIST Tech-I), an initiative promoted by the US President, where the team competed against 900 technological developments from all over the world. More...


The device is called the Glucosalarm (Brownsville, TX, USA) and it uses two 70 mL bottles, one contains an enzyme and the other one contains a cleaning solution, which last for 140 measurements and are easily replaceable. The device uses a light sensor that detects the frequency of glucose in urine and measures it in 15 to 40 seconds. Only one drop of urine is needed and this can be done when the patient uses the toilet and there is no need for painful blood testing. Another reason for not having a constant monitoring is the cost. A glucometer costs less than USD 30, but the test strips are expensive, as well as needles and needle holders, which is money that is not available to everyone. Glucosalarm will cost approximately USD 120 to USD 140 and the readings will cost less than a penny per measurement.

Currently, the device is in the third prototype and tests are performed with patients. It also has a patent in Mexico and the United States, and two medical device companies with international presence have shown interest in manufacturing it. Glucosalarm is expected to be released in the USA and Mexico in late 2016 and early 2017, once the necessary authorizations are obtained from the US Food and Drug Administration (FDA, Silver Springs, MD, USA) and the Mexican Federal Commission for the Protection against Sanitary Risk (COFEPRIS; Benito Juárez, Mexico).

Related Links:

Chihuahua Institute of Technology
GlucosAlarm 
US Food and Drug Administration 



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.